11/14
09:14 am
dmac
DiaMedica Therapeutics (NASDAQ:DMAC) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Medium
Report
DiaMedica Therapeutics (NASDAQ:DMAC) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
11/13
10:07 am
dmac
DiaMedica signals revised ReMEDy2 trial timeline and expansion cohort completion for DM199 amid cash runway into 2027 [Seeking Alpha]
Medium
Report
DiaMedica signals revised ReMEDy2 trial timeline and expansion cohort completion for DM199 amid cash runway into 2027 [Seeking Alpha]
11/13
10:07 am
dmac
DiaMedica Therapeutics Inc. (DMAC) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
DiaMedica Therapeutics Inc. (DMAC) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/12
05:11 pm
dmac
DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
High
Report
DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
11/12
04:30 pm
dmac
DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
High
Report
DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
11/10
08:30 am
dmac
DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London [Yahoo! Finance]
11/10
08:15 am
dmac
DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
Low
Report
DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
11/6
04:15 pm
dmac
DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025
Medium
Report
DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025
10/30
08:13 am
dmac
DiaMedica Therapeutics (NASDAQ:DMAC) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
Medium
Report
DiaMedica Therapeutics (NASDAQ:DMAC) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
10/30
08:10 am
dmac
DiaMedica Therapeutics (NASDAQ:DMAC) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Medium
Report
DiaMedica Therapeutics (NASDAQ:DMAC) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
10/4
03:06 am
dmac
DiaMedica Therapeutics (NASDAQ:DMAC) was upgraded by analysts at
Wall St
Neutral
Report
DiaMedica Therapeutics (NASDAQ:DMAC) was upgraded by analysts at
Wall St
9/29
04:34 pm
dmac
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) [Yahoo! Finance]
Low
Report
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) [Yahoo! Finance]
9/29
04:15 pm
dmac
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Low
Report
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
9/10
01:13 am
dmac
DiaMedica Therapeutics (NASDAQ:DMAC) was upgraded by analysts at
Wall St
Low
Report
DiaMedica Therapeutics (NASDAQ:DMAC) was upgraded by analysts at
Wall St